HealthCare Global Enterprises Ltd. ( (IN:HCG) ) has shared an update.
HealthCare Global Enterprises Ltd. has announced a significant transaction involving the sale of up to 54% of its diluted voting share capital to Hector Asia Holdings II Pte. Ltd. and KIA EBT II Scheme 1. This move, facilitated by a share purchase agreement, marks a substantial shift in ownership, with Purchaser 1 gaining sole control and the current promoters being reclassified as public shareholders. The transaction is expected to impact the company’s governance and strategic direction, as key figures like Dr. B.S. Ajaikumar transition to non-executive roles, and amendments to the articles of association are set to take effect, pending shareholder approval.
More about HealthCare Global Enterprises Ltd.
HealthCare Global Enterprises Ltd. operates in the healthcare industry, focusing on oncology services. The company provides specialized services and treatments for cancer patients, positioning itself as a leading player in the field of cancer care.
YTD Price Performance: 2.95%
Average Trading Volume: 19,389
Current Market Cap: 69.7B INR
Find detailed analytics on HCG stock on TipRanks’ Stock Analysis page.